New insider activity at Lexeo Therapeutics, Inc. ( (LXEO) ) has taken place on February 22, 2025.
In recent transactions involving Lexeo Therapeutics, Inc., CEO Richard Nolan Townsend sold 4,326 shares of the company’s stock, generating $19,077 from the sale. Additionally, CMO Eric Adler parted with 2,359 shares, bringing in $10,403.
More about Lexeo Therapeutics, Inc.
YTD Price Performance: -39.58%
Average Trading Volume: 251,636
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $133.3M